Genomma Enjoys Strong Q2 Thanks To Big Gains in US
Executive Summary
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
You may also be interested in...
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.
Sweden Seeks To Tackle Opioid Overdose Deaths With Naloxone Rx-To-OTC Switch
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.
Norway's Orkla Prioritizes Seeing Off Private-Label Consumer Health Challenge
Alongside addressing the threat posed by private-label, Orkla Health CEO Isabelle Ducellier will over the coming three years focus on building global brands and simplifying the value chain to improve efficiency and extract synergies.